Picture of Ascendis Pharma A/S logo

ASND — Ascendis Pharma A/S News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Ascendis Pharma A/S Reports Q2 Loss Per Share Eur 1.25

Aug 28 (Reuters) - Ascendis Pharma A/S  ASND.O :
    * REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS
    * Q2 LOSS PER SHARE EUR 1.25
    * Q2 REVENUE EUR 3.2 MILLION
    * Q2 REVENUE ESTIMATE EUR 253,000 -- REFINITIV IBES DATA
    * Q2 EARNINGS PER SHARE ESTIMATE EUR -1.21 -- REFINITIV IBES
DATA
    * AS OF JUNE 30, 2019, ASCENDIS HAD CASH AND CASH
EQUIVALENTS OF
EUR 690.4 MILLION COMPARED TO EUR 696.7 MILLION AS OF MARCH 31,
2019

Source text for Eikon:  ID:nGNX52ZkS3 
Further company coverage:  ASND.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Ascendis Pharma A/S

See all news